RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) on November 25 and set a price target of $50.00. The ...

On Tuesday, Moderna Inc (MRNA) stock saw a decline, ending the day at $42.05 which represents a decrease of $-1.61 or -3.69% from the prior close of $43.66. The stock opened at $43.13 and touched a ...

We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a ...

This segment is sponsored by the Altoona Center for Clinical Research ALTOONA, Pa. (WTAJ) — A Clinical Trial to Evaluate an ...

As the cold sets in and we are spending most of our time indoors with family and friends, we have to pay attention because a ...

The Nasdaq-100 index tracks the largest 100 non-financial companies on the Nasdaq stock exchange. Although it's not a part of the U.S. stock market's big three indexes (S&P 500, Nasdaq Composite, and ...

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...

Moderna stock is undervalued with a $97 price target, strong COVID-19 revenue, promising pipeline, and long-term growth. Read ...

As the new administration prepares to take over, there will be no time to waste in tackling enormous challenges in a region ...

Schools participating in the Science Series program get an exclusive Mets-focused science curriculum to implement in their classrooms. The Mets provide teachers with six lesson plan topics to ...

An uncommon reaction left Cristina Calvert fighting for her life. She survived and is healthy, but others with injuries are ...

In an industry where humanoids are still not viable, Proxie is a collaborative robot that aims to fill the gap by bringing ...